No Data
No Data
Express News | Watching Novartis; Traders Circulating The Co Lost A Ruling From FDA Allowing For Generic Ernestro
Novartis to Collaborate With Dren Bio on Bispecific Antibody Therapies
Is a Beat in the Cards for Incyte (INCY) in Q2 Earnings?
Dren Bio Announces Strategic Collaboration With Novartis To Develop Novel Targeted Myeloid Engagers For Cancer; Dren Bio To Receive Total Upfront Consideration Of $150M And Is Eligible To Receive Milestone Payments And Tiered Royalties
Dren Bio Announces Strategic Collaboration With Novartis to Develop Novel Targeted Myeloid Engagers for Cancer
Berenberg Raises Price Target on Novartis to CHF86 From CHF77, Maintains Hold Rating
No Data